» Articles » PMID: 16461919

Smooth Muscle of Telokin-deficient Mice Exhibits Increased Sensitivity to Ca2+ and Decreased CGMP-induced Relaxation

Overview
Specialty Science
Date 2006 Feb 8
PMID 16461919
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Cyclic nucleotides can relax smooth muscle without a change in [Ca2+]i, a phenomenon termed Ca2+ desensitization, contributing to vasodilation, gastrointestinal motility, and airway resistance. The physiological importance of telokin, a 17-kDa smooth muscle-specific protein and target for cyclic nucleotide-induced Ca2+ desensitization, was determined in telokin null mice bred to a congenic background. Telokin null ileal smooth muscle homogenates compared to wild type exhibited an approximately 30% decrease in myosin light-chain phosphatase (MLCP) activity, which was reflected in a significant leftward shift (up to 2-fold at pCa 6.3) of the Ca2+ force relationship accompanied by an increase in myosin light-chain phosphorylation. No difference in the Ca2+ force relationship occurred in telokin WT and knockout (KO) aortas, presumably reflecting the normally approximately 5-fold lower telokin content in aorta vs. ileum smooth muscle. Ca2+ desensitization of contractile force by 8-Br-cGMP was attenuated by 50% in telokin KO intestinal smooth muscle. The rate of force relaxation reflecting MLCP activity, in the presence of 50 microM 8-Br-cGMP, was also significantly slowed in telokin KO vs. WT ileum and was rescued by recombinant telokin. Normal thick filaments in telokin KO smooth muscles indicate that telokin is not required for filament formation or stability. Results indicate that a primary role of telokin is to modulate force through increasing MLCP activity and that this effect is further potentiated through phosphorylation by cGMP in telokin-rich smooth tissues.

Citing Articles

p90RSK2, a new MLCK mediates contractility in myosin light chain kinase null smooth muscle.

Kalra J, Artamonov M, Wang H, Franke A, Markowska Z, Jin L Front Physiol. 2023; 14:1228488.

PMID: 37781225 PMC: 10533999. DOI: 10.3389/fphys.2023.1228488.


Myocardin regulates exon usage in smooth muscle cells through induction of splicing regulatory factors.

Liu L, Kryvokhyzha D, Rippe C, Jacob A, Borreguero-Munoz A, Stenkula K Cell Mol Life Sci. 2022; 79(8):459.

PMID: 35913515 PMC: 9343278. DOI: 10.1007/s00018-022-04497-7.


Regulation of myosin light-chain phosphorylation and its roles in cardiovascular physiology and pathophysiology.

Ito M, Okamoto R, Ito H, Zhe Y, Dohi K Hypertens Res. 2021; 45(1):40-52.

PMID: 34616031 DOI: 10.1038/s41440-021-00733-y.


Anthelmintic resistance and homeostatic plasticity (Brugia malayi).

Kashyap S, Verma S, McHugh M, Wolday M, Williams P, Robertson A Sci Rep. 2021; 11(1):14499.

PMID: 34262123 PMC: 8280109. DOI: 10.1038/s41598-021-93911-4.


Aqueous Tuber Extracts of (Kotschy ex Schweinf.) Torre and Hillc. (Fabaceae). Possess Significant Antidiarrheal Activity and Spasmolytic Effect Possibly Mediated by Modulation of Nitrous Oxide System, Voltage-Gated Calcium Channels, and....

Mapesa W, Waweru M, Bukachi F, Wafula K Front Pharmacol. 2021; 12:636879.

PMID: 33796023 PMC: 8007759. DOI: 10.3389/fphar.2021.636879.


References
1.
Surks H, Mochizuki N, Kasai Y, Georgescu S, Tang K, Ito M . Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha. Science. 1999; 286(5444):1583-7. DOI: 10.1126/science.286.5444.1583. View

2.
Wakeland E, Morel L, Achey K, Yui M, Longmate J . Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol Today. 1997; 18(10):472-7. DOI: 10.1016/s0167-5699(97)01126-2. View

3.
MacDonald J, Walker L, Nakamoto R, Gorenne I, Somlyo A, Somlyo A . Phosphorylation of telokin by cyclic nucleotide kinases and the identification of in vivo phosphorylation sites in smooth muscle. FEBS Lett. 2000; 479(3):83-8. DOI: 10.1016/s0014-5793(00)01884-6. View

4.
MacDonald J, Borman M, Muranyi A, Somlyo A, Hartshorne D, Haystead T . Identification of the endogenous smooth muscle myosin phosphatase-associated kinase. Proc Natl Acad Sci U S A. 2001; 98(5):2419-24. PMC: 30153. DOI: 10.1073/pnas.041331498. View

5.
Muranyi A, Zhang R, Liu F, Hirano K, Ito M, Epstein H . Myotonic dystrophy protein kinase phosphorylates the myosin phosphatase targeting subunit and inhibits myosin phosphatase activity. FEBS Lett. 2001; 493(2-3):80-4. DOI: 10.1016/s0014-5793(01)02283-9. View